$ESAB SEC Filings

Filed On	Filing
07 Oct 2026	SCHEDULE 13G/A
02 Oct 2026	Form 4: Martin Sebastien, Director Received 198 shares by exercise or conversion
02 Oct 2026	Form 4: Rales Mitchell P, Director Received 892 shares as a grant or award
01 Oct 2026	Form 4: Teirlinck Didier P, Director Granted 200 Deferred Stock Units
01 Oct 2026	Form 4: Lutz Robert S, Director Granted 494 Deferred Stock Units
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	Form 4: Jordan Rhonda L, Director Received 1,000 shares by exercise or conversion ($33.3K) · Sold 1,000 shares ($95K)
07 Aug 2026	144
06 Aug 2026	8-K/A: Financial Statements and Exhibits The accompanying notes are an integral part of these unaudited condensed consolidated interim financial statements.
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	SCHEDULE 13G
17 Jul 2026	Form 4: Bhagwakar Ranjana N, EVP, Business Operations Granted 15,777 Restricted Stock Units
06 Jul 2026	Form 4: Bhagwakar Ranjana N, EVP, Business Operations Granted 9,048 Restricted Stock Units · Granted 7,056 Employee Stock Options (right to buy) · Granted 58,056 Performance Stock Option (right to buy)
06 Jul 2026	Form 3: Bhagwakar Ranjana N, EVP, Business Operations No securities owned
02 Jul 2026	Form 4: Rales Mitchell P, Director Received 596 shares as a grant or award
02 Jul 2026	Form 4: Lutz Robert S, Director Granted 330 Deferred Stock Units
02 Jul 2026	Form 4: Teirlinck Didier P, Director Granted 134 Deferred Stock Units
26 Jun 2026	PROSPECTUS SUPPLEMENT
15 Jun 2026	144

Comments